Zeaxanthin Supplementation Eye Health Randomized Trial: What the Evidence Says

Quick Answer

Zeaxanthin Supplementation Eye Health Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are randomized trial, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

• This page is generated only from sources stored in the Migaku evidence knowledge base.
• Current evidence mix: 2 randomized trial.
• Claims should be interpreted with the source type, study design, population, and publication date in mind.
• This article is educational and does not replace care from a qualified clinician.

Evidence Map

What The Sources Report

• It aims to provide high-quality evidence on the impact of dietary carotenoid supplementation on visual function in the normal Chinese population, supporting nutritionists and physicians in improving visual function through dietary interventions and paving the way for future large-scale clinical studies. [Xu Kan (2026); evidence level 2]
• These carotenoids are specifically concentrated in the macula lutea via high-affinity binding proteins and specialised transport and metabolic proteins.However, humans are unable to synthesise carotenoids such as L and Z. [Xu Kan (2026); evidence level 2]
• This vulnerability is a result of cumulative oxidative stress, declining antioxidant defenses, and the gradual deterioration of retinal pigment epithelial (RPE) cells over time. [Baek Hyang-Im (2026); evidence level 2]
• However, emerging evidence suggests that macular vulnerability is not limited to older adults. [Baek Hyang-Im (2026); evidence level 2]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

There is trial evidence in the current set, but population and intervention details still matter. For zeaxanthin supplementation eye health randomized trial, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

References

• Xu Kan (2026). Effect of carotenoids supplementation on visual function in Chinese adults free of retinal disease: protocol for the CSV double-blind, randomised, placebo-controlled trial. DOI: 10.1136/bmjopen-2025-112364. PMCID: PMC13034290. PMID: 41887628. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13034290/
• Baek Hyang-Im (2026). Effects of Long-Term Supplementation with Centella asiatica (L.) Urb. Extract (CA-HE50) on Macular Pigment Optical Density: A Randomized, Double-Blind, Placebo-Controlled Trial. DOI: 10.3390/nu18060905. PMCID: PMC13029741. PMID: 41901080. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13029741/

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.